PORTFOLIO NEWS NGM Bio Presents Comprehensive Findings from 24-Week Phase 2 Study (Cohort 4) of Aldafermin in Oral Plenary Presentation at The Digital International Liver Congress™ (ILC) 2020 and Announces Enrollment Completed in Phase 2b ALPINE 2/3 Study August 29, 2020 Read More » RAPT Therapeutics Reports Second Quarter 2020 Financial Results August 13, 2020 Read More » NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial Results August 12, 2020 Read More » Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress August 10, 2020 Read More » Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates August 6, 2020 Read More » Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update August 5, 2020 Read More » ORIC Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Update August 5, 2020 Read More » Nura Bio (formerly Proneurotech) Launches to Discover and Develop Neuroprotective Drugs, Backed by $73M Series A Financing July 29, 2020 Read More » NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) July 27, 2020 Read More » Nurix Therapeutics Announces Pricing of $209 Million Initial Public Offering July 23, 2020 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
NGM Bio Presents Comprehensive Findings from 24-Week Phase 2 Study (Cohort 4) of Aldafermin in Oral Plenary Presentation at The Digital International Liver Congress™ (ILC) 2020 and Announces Enrollment Completed in Phase 2b ALPINE 2/3 Study August 29, 2020 Read More »
NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial Results August 12, 2020 Read More »
Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress August 10, 2020 Read More »
Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates August 6, 2020 Read More »
Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update August 5, 2020 Read More »
ORIC Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Update August 5, 2020 Read More »
Nura Bio (formerly Proneurotech) Launches to Discover and Develop Neuroprotective Drugs, Backed by $73M Series A Financing July 29, 2020 Read More »
NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) July 27, 2020 Read More »
Nurix Therapeutics Announces Pricing of $209 Million Initial Public Offering July 23, 2020 Read More »
